Hepatoprotective effect of manganese chloride against CCl4-induced liver injury in rats. 2013

Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran, eidi@srbiau.ac.ir.

The aim of the present study is to evaluate the protective effect of manganese chloride against carbon tetrachloride (CCl4)-induced liver injury in rats. Manganese chloride (0.001, 0.01, 0.05 and 0.1 g/kg bw) was administered intragastrically for 28 consecutive days to male CCl4-treated rats. The hepatoprotective activity was assessed using various biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyltransferase (GGT) and superoxide dismutase (SOD). Histopathological changes in the liver of different groups were also studied. Administration of CCl4 increased the serum ALT, AST, ALP and GGT but decreased SOD levels in rats. Treatment with manganese chloride significantly attenuated these changes to nearly normal levels. The animals treated with manganese chloride have shown decreased necrotic zones and hepatocellular degeneration when compared to the liver exposed to CCl4 intoxication alone. Thus, the histopathological studies also supported the protective effect of manganese chloride. Therefore, the results of this study suggest that manganese chloride exerts hepatoprotection via promoting antioxidative properties against CCl4-induced oxidative liver damage.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D002251 Carbon Tetrachloride A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed) Tetrachloromethane,Tetrachloride, Carbon
D002712 Chlorides Inorganic compounds derived from hydrochloric acid that contain the Cl- ion. Chloride,Chloride Ion Level,Ion Level, Chloride,Level, Chloride Ion
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
September 2017, Journal of basic and clinical physiology and pharmacology,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
January 2020, Pakistan journal of biological sciences : PJBS,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
April 1985, Experimental and molecular pathology,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
February 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
February 2006, Fitoterapia,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
January 2008, Fitoterapia,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
August 2014, Pharmaceutical biology,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
November 2012, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
July 2008, Indian journal of experimental biology,
Akram Eidi, and Pejman Mortazavi, and Khodabakhsh Behzadi, and Ali Haeri Rohani, and Shahabeddin Safi
January 2014, BioMed research international,
Copied contents to your clipboard!